What changed in this filing

/stocks — the workspaceLOADING

Item 1. Legal Proceedings

2024-10-22 compared with 2024-07-22 · 27 added, 29 removed, 54 unchanged (51% of the section changed)

15 unchanged sentences

As of the time of this

filing, the Company has paid the full amount toward the settlement amount.

The remaining balance is zero

filing, the Company has paid the full amount toward the settlement amount, leaving no remaining balance.

In March 2024, the Company and Kopple again amended

18 unchanged sentences

fiscal year 2025.

On March 26, 2019, various stockholders of

the Company controlling a combined total of more than 27.5 million shares delivered a signed written consent to the Company removing

Ronald Buschur as a member of the Company’s Board and electing Cipora Lavut as a director of the Company.

2019, those same stockholders delivered a further signed written consent to the Company removing William Anderson and Si Ryong Yu as

members of the Company’s Board and electing Robert Lempert and David Mann as directors of the Company.

These written consents

represented a majority of the outstanding shares of the Company’s common stock as of March 26, 2019, and March 27,

2019, respectively.

Because of Aura’s refusal to recognize the legal effectiveness of the consents, on April 8, 2019, the

stockholders filed suit in the Court of Chancery of the State of Delaware pursuant to Section 225 of the Delaware General

Corporations Law, seeking an order confirming the validity of the consents and declaring that Aura’s Board consists of

Douglas and Mr.

On March 26, 2019, various stockholders of the

Company controlling a combined total of more than 27.5 million shares delivered a signed written consent to the Company removing Ronald

Buschur as a member of the Company’s Board and electing Cipora Lavut as a director of the Company.

On March 27, 2019, those

same stockholders delivered a further signed written consent to the Company removing William Anderson and Si Ryong Yu as members of the

Company’s Board and electing Robert Lempert and David Mann as directors of the Company.

These written consents represented a majority

of the outstanding shares of the Company’s common stock as of March 26, 2019, and March 27, 2019, respectively.

of Aura’s refusal to recognize the legal effectiveness of the consents, on April 8, 2019, the stockholders filed suit in the

Court of Chancery of the State of Delaware pursuant to Section 225 of the Delaware General Corporations Law, seeking an order confirming

the validity of the consents and declaring that Aura’s Board consists of Ms.

Diaz-Versón, Jr.

On July 8, 2019 the

Court of Chancery entered final judgment in favor of the stockholder plaintiffs, confirming that (a) Ronald Buschur, Si Ryong Yu and

William Anderson had been validly removed by the holders of a majority of the Company’s outstanding stock acting by written

consent (b) Ms.

Lempert had been validly elected by the holders of a majority of the Company’s

outstanding stock acting by written consent, and (c) the Company’s Board of Directors validly consists of Cipora Lavut, David

Mann, Robert Lempert, Gary Douglas and Salvador Diaz-Versón, Jr.

On July 8, 2019 the Court of Chancery entered final judgment in favor of the stockholder plaintiffs,

confirming that (a) Ronald Buschur, Si Ryong Yu and William Anderson had been validly removed by the holders of a majority of the Company’s

outstanding stock acting by written consent (b) Ms.

Lempert had been validly elected by the holders of a majority

of the Company’s outstanding stock acting by written consent, and (c) the Company’s Board of Directors validly consists of

Cipora Lavut, David Mann, Robert Lempert, Gary Douglas and Salvador Diaz-Versón, Jr.

As a result of prior management’s unsuccessful

opposition to this stockholders’ action filed in the Court of Chancery, such stockholders may be potentially entitled to

recoup their litigation costs from the Company under Delaware’s corporate benefit doctrine and/or other legal provisions.

date, no final determination has been made as to the amount of recoupment, if any, to which such stockholders may be entitled.

opposition to this stockholders’ action filed in the Court of Chancery, such stockholders may be potentially entitled to recoup

their litigation costs from the Company under Delaware’s corporate benefit doctrine and/or other legal provisions.

To date, no final

determination has been made as to the amount of recoupment, if any, to which such stockholders may be entitled.

In June 2022, Melvin Gagerman, the Company’s

9 unchanged sentences

actions in opposing the valid 2019 stockholder consent action.

In addition to the other information set forth in this report, you

should carefully consider the risk factors disclosed in Item 1A, “Risk Factors,” of the Company’s Fiscal 2024 Annual

Report on Form 10-K issued on June 4, 2024.

In addition to the other information set forth

in this report, you should carefully consider the risk factors disclosed in Item 1A, “Risk Factors,” of the Company’s

Fiscal 2024 Annual Report on Form 10-K issued on June 4, 2024.

Unregistered Sales of Equity Securities

and Use of Proceeds

During the three-months ended May 31, 2024, the Company issued 4,455,600

shares of common stock for approximately $1,117 in net cash.

During the six-months ended August 31, 2024, the

Company issued 7,875,600 shares of common stock for approximately $1,763 in net cash.

Defaults Upon Senior Securities.

2 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 1. Legal Proceedings